Evidence map›Paper›PMID 23355050›Full record

ArticleJournal of medical ethics2013

Preventive misconception and adolescents' knowledge about HIV vaccine trials.

Mary A Ott, Andreia B Alexander, Michelle Lally, John B Steever, Gregory D Zimet, Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions

Abstract read
In one paragraph

Article in Journal of medical ethics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Minors' and Young Adults' Experiences of the Research Consent Process in a Phase II Safety Study of Pre-exposure Prophylaxis for HIV.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2017
    Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Facilitators and Barriers to Participation in PrEP HIV Prevention Trials Involving Transgender Male and Female Adolescents and Emerging Adults.AIDS education and prevention : official publication of the International Society for AIDS Education · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mary A OttSection of Adolescent Medicine, Department of Pediatrics, Indiana University School of Medicine, , Indianapolis, Indiana, USA.
Andreia B Alexander
Michelle Lally
John B Steever
Gregory D Zimet
Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions

Funding

Adol. Medicine Trials Network for HIV/AIDS InterventionsU01HD040474 · NICHD · WESTAT, INC. · PI HARRIS, DONALD ROBERT · 2001 to 2016
$114.4M
LEADERSHIP GROUP FOR ADOLESCENT MEDICINE TRIALS NETWORKU01HD040533 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILSON, CRAIG M · 2001 to 2016
$76.4M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
The Developmental and Relationship Contexts of Sexual Abstinence Among AdolescentK23HD049444 · NICHD · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI OTT, MARY A. · 2006 to 2010
$687k
NIAID NIH HHS P30 AI042853NICHD NIH HHS 1 K23 HD 049444-01NICHD NIH HHS 5 U01 HD 40474NICHD NIH HHS 5 U01 HD 40533NICHD NIH HHS K23 HD049444NICHD NIH HHS U01 HD040474NICHD NIH HHS U01 HD040533
6 · The paper itself

Abstract

objectiveAdolescents have had very limited access to research on biomedical prevention interventions despite high rates of HIV acquisition. One concern is that adolescents are a vulnerable population, and trials carry a possibility of harm, requiring investigators to take additional precautions. Of particular concern is preventive misconception, or the overestimation of personal protection that is afforded by enrolment in a prevention intervention trial.

methodsAs part of a larger study of preventive misconception in adolescent HIV vaccine trials, we interviewed 33 male and female 16-19-year-olds who have sex with men. Participants underwent a simulated HIV vaccine trial consent process, and then completed a semistructured interview about their understanding and opinions related to enrolment in a HIV vaccine trial. A grounded theory analysis looked for shared concepts, and focused on the content and process of adolescent participants' understanding of HIV vaccination and the components of preventive misconception, including experiment, placebo and randomisation.

resultsAcross interviews, adolescents demonstrated active processing of information, in which they questioned the interviewer, verbally worked out their answers based upon information provided, and corrected themselves. We observed a wide variety of understanding of research concepts. While most understood experiment and placebo, fewer understood randomisation. All understood the need for safer sex even if they did not understand the more basic concepts.

conclusionsEducation about basic concepts related to clinical trials, time to absorb materials and assessment of understanding may be necessary in future biomedical prevention trials.

Indexed as

AIDS VaccinesHealth Knowledge, Attitudes, PracticeAdolescentAdolescent DevelopmentBiomedical ResearchComprehensionDecision MakingEthics, ResearchFemaleHIV InfectionsHumansMaleRandomized Controlled Trials as TopicResearch SubjectsSexual BehaviorVaccinationAIDS VaccinesHIV Infection and AIDSMinors/Parental ConsentResearch EthicsResearch on Special Populations

Identifiers

PMID23355050
PMCPMC3677956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.